BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11884935)

  • 1. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
    Rosenau J; Bahr MJ; von Wasielewski R; Mengel M; Schmidt HH; Nashan B; Lang H; Klempnauer J; Manns MP; Boeker KH
    Transplantation; 2002 Feb; 73(3):386-94. PubMed ID: 11884935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
    Korda D; Doros A; Piros L; Gerlei Z; Haboub-Sandil A; Mándli T; Fazakas J; Deák ÁP; Máthé Z
    Transplant Proc; 2019 May; 51(4):1251-1253. PubMed ID: 31101208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following liver transplantation for metastatic neuroendocrine tumors.
    Grąt M; Remiszewski P; Smoter P; Wronka KM; Grąt K; Lewandowski Z; Koperski L; Górnicka B; Pacho R; Zborowska H; Patkowski W; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2766-9. PubMed ID: 25380913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
    Moris D; Tsilimigras DI; Ntanasis-Stathopoulos I; Beal EW; Felekouras E; Vernadakis S; Fung JJ; Pawlik TM
    Surgery; 2017 Sep; 162(3):525-536. PubMed ID: 28624178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables.
    Sher LS; Levi DM; Wecsler JS; Lo M; Petrovic LM; Groshen S; Ji L; Uso TD; Tector AJ; Hamilton AS; Marsh JW; Schwartz ME
    J Surg Oncol; 2015 Aug; 112(2):125-32. PubMed ID: 26171686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.
    Pascher A; Klupp J; Neuhaus P
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):637-48. PubMed ID: 16183532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplant for neuroendocrine tumor metastatic to the liver: literature review and report of extirpation at 16-year recurrence.
    Ortiz J; Balasubramanian M; Brown T; Cetrulo L
    Exp Clin Transplant; 2015 Feb; 13(1):86-91. PubMed ID: 25343464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for metastatic neuroendocrine tumors.
    Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
    Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification.
    Xin W; Paulino AF
    Ann Diagn Pathol; 2002 Aug; 6(4):205-10. PubMed ID: 12170450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
    van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
    Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
    Rossi RE; Burroughs AK; Caplin ME
    Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors.
    Olausson M; Friman S; Herlenius G; Cahlin C; Nilsson O; Jansson S; Wängberg B; Ahlman H
    Liver Transpl; 2007 Mar; 13(3):327-33. PubMed ID: 17318853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for treatment of metastatic neuroendocrine tumors.
    Ahlman H; Friman S; Cahlin C; Nilsson O; Jansson S; Wängberg B; Olausson M
    Ann N Y Acad Sci; 2004 Apr; 1014():265-9. PubMed ID: 15153443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of Ki67 and p53 protein in small bowel stromal tumor immunopositive for CD117].
    Liu P; Na J; Zhang J; Zhang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 35(1):28-32. PubMed ID: 12920804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is liver transplantation as surgical therapy concept in metastases of neuroendocrine tumors justified?].
    Lang H; Oldhafer KJ; Schlitt HJ; Scheumann GF; Ringe B; Pichlmayr R
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():416-8. PubMed ID: 9101890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
    Rao J; Seligson D; Visapaa H; Horvath S; Eeva M; Michel K; Pantuck A; Belldegrun A; Palotie A
    Cancer; 2002 Sep; 95(6):1247-57. PubMed ID: 12216092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
    Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
    Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.